Navigation Links
Achieving Optimal Performance from Single-Use Platforms, New Life Science Webinar Hosted by Xtalks

Toronto, Canada (PRWEB) March 11, 2013

Balancing flexibility and costs under an accelerated timeline is a challenge for any biotech firm. This webinar will describe the quality and regulatory points to consider, as well as the economic factors that support and justify expansion. Speakers from Fujifilm Diosynth Biotechnologies — a Contract Development & Manufacturing facility that has a successful history of supplying both clinical and commercial cell culture derived human therapeutics using stainless steel bioreactor platforms — will discuss the design basis for “all” single use manufacturing processes. They exploit the single use concept from ‘vial thaw through to bulk monoclonal antibody drug substance’.

The keys to maximizing the investment in a cGMP cell culture manufacturing facility and achieving operational benefits start during process development and initial process design.

This webinar will examine:

  •     The upstream and downstream development platforms that need to be modified and optimized to support efficient process definition and effective technology transfer to fully exploit single use bioprocess technologies. A case study involving Fujifilm Diosynth Biotechnologies’ cell line development will be presented.
  •     How upfront development of a robust single use process platform streamlines manufacturing operations and provides advantages in technology transfer via elegant process design
  •     How these advantages in operational robustness and process transfer efficiency allow for rapid process portability to enable manufacturing flexibility on a global scale

For more information about this event or to register, visit:

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

Karen Lim (416) 977-6555 ext 227

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
2. Ian Somerhalder Raises Big Money for the Environment; Optimal Chemical Comments His Effort Proves He's a True Green Celebrity
3. Cold Adds Up to Sandy Victims' Mold Problems; Optimal Chemical Reaches Out to Help by Advising the Use of Molderizer
4. Stoneville Cotton Seed from Bayer CropScience Celebrates 90 Years of Performance
5. Bayer CropScience and MS Technologies’ Balance GT Soybean to Usher in Next Era of Performance and Weed Control
6. Elsevier and Kanazawa University in Japan Collaborate to Map Universitys Research Performance
7. New nanotech fiber: Robust handling, shocking performance
8. Thomson Reuters Online Resource Offers Key Trends in Scientific Research and Performance Analysis
9. Puritan Awarded U.S. Patent for High-Performance HydraFlock® Swab
10. Growers Choose the Bayer CropScience LibertyLinkSystem for Yield and Performance
11. Automated Online Sample Preparation Comes to Waters UltraPerformance Liquid Chromatography (UPLC) Platform
Post Your Comments:
(Date:11/27/2015)... November 27, 2015 ... popularity of companion diagnostics is one of ... market with pharmaceutical companies and diagnostic manufacturers ... tests. . --> ... report on global cancer biomarkers market spread ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... President and CEO of Neurocrine Biosciences, will be presenting ... New York . ... website approximately 5 minutes prior to the presentation to ... the presentation will be available on the website approximately ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
Breaking Biology Technology:
(Date:11/18/2015)... York , November 18, 2015 ... Research has published a new market report titled  Gesture ... Trends, and Forecast, 2015 - 2021. According to the report, ... 2014 and is anticipated to reach US$29.1 bn by ... 2021. North America dominated ...
(Date:11/17/2015)... , November 17, 2015 ... au 19 novembre  2015.  --> Paris ... --> DERMALOG, le leader de l,innovation biométrique, ... la fois passeports et empreintes sur la même surface ... les passeports et l,autre pour les empreintes digitales. Désormais, ...
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
Breaking Biology News(10 mins):